Welcome to the IPC Virtual Psoriasis Masterclass for Europe, an exclusive educational opportunity for early- to mid-career dermatologists and final-year residents actively managing and treating psoriasis. Focusing on fostering a small-group environment, this FREE program offers an intimate, personalized learning experience, ensuring each participant receives the utmost attention and support.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions, and question-and-answer sessions, attendees will gain practical, important information for their clinical practice.
The Masterclass is limited to 60 participants, selected from those dedicated to advancing their expertise in managing and treating psoriasis. If you are a Dermatologist or a final-year resident from Europe with a solid background in dermatology, this program is designed for you.
Thank you for your interest in attending the upcoming masterclass. Registration is now closed. If you would like to register for the class, please email masterclass@psoriasiscouncil.org.
Brief Summary of the Course
The IPC Psoriasis Masterclass for Europe is a 10-hour intensive educational program designed for early- to mid-career dermatologists and final-year residents interested in specializing in psoriasis care. With a focus on fostering a small group environment, the Masterclass provides a personalized learning experience, empowering participants to excel in their careers and become leaders in the field of psoriasis.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
Topics Covered
Prerequisites
The IPC Virtual Psoriasis Masterclass is designed for early- to mid-career dermatologists and final-year residents with a strong foundation in dermatology, who are making treatment decisions and managing patients with psoriasis.
EPIDEMIOLOGY AND PATHOGENESIS
WELCOME + INTRODUCTION
Lone Skov, MD, PhD, Denmark
Epidemiology: The Size of the Problem
Juul van der Reek, MD, PhD, Netherlands
Genetic Determinants of Disease
Mari Løset, MD, PhD, Norway
Psoriasis Pathophysiology and Mechanisms
Antonios Kolios, MD, Switzerland
Understanding Patient Goals
Ingvar Ingvarsson, Iceland
Clinical Cases: Shared Decision Making
Malin Assarsson, MD, PhD, Sweden
Closing Comments
Antonios Kolios, MD, Switzerland
CLINICAL PHENOTYPES
WELCOME + INTRODUCTION
Antonios Kolios, MD, Switzerland
Clinical Phenotypes
Brian Kirby, MD, FRCPI, Ireland
Psoriasis in Children
Amy Paller, MS, MD, United States
What’s New in Pustular Psoriasis
Jose-Manuel Carrascosa Carrillo, MD, PhD, Spain
Environmental Disease Triggers and Risk Factors of Disease Onset
Albert Duvetorp, MD, PhD, Sweden
Clinical Cases: Pediatric Psoriasis
Ralph Vighi da Rosa, MSc, MD, Brazil
Closing Comments
Ravi Ramessur, PhD, United Kingdom
MANGEMENT APPROACHES
WELCOME + INTRODUCTION
Ravi Ramessur, PhD, United Kingdom
Topicals: When and How to Use
Peter van de Kerkhof, MD, PhD, Netherlands
Should We Be Integrating Home Phototherapy into Our Psoriasis Care Toolkit?
Cobly Evans, MD, United States
Conventional Systemic Treatment and Small Molecules
Diamant Thaçi, MD, PhD, Germany
Biologics: Where are We Now?
Paolo Gisondi, MD, Italy
Refining Treatment Strategies in Psoriasis
Jonathan Barker, MD, FRCP, United Kingdom
Closing Comments
Lone Skov, MD, PhD, Denmark
COMORBIDITIES
WELCOME + INTRODUCTION
Lone Skov, MD, PhD, Denmark
Psoriasis Arthritis
Anna López Ferrer, MD, PhD, Spain
Psoriasis and Cardiovascular Diseases
Ravi Ramessur, PhD, United Kingdom
Psoriasis and Metabolic Disease, including Liver Disease
Lone Skov, MD, PhD, Denmark
Psoriasis, Infections, and Cancer: What to Do
Zenas Yiu, MSc, MBChB, PhD, MRCP, United Kingdom
Clinical Case: Psoriasis During Pregnancy
Shekhar Neema, MD, India
Closing Comments
Antonios Kolios, MD, Switzerland
THE FUTURE, CHALLENGING CASE PRESENTATIONS AND EXPERT DISCUSSION
WELCOME + INTRODUCTION
Antonios Kolios, MD, Switzerland
AI and Psoriasis
Alexander Navarini, MD, PhD, Switzerland
Challenging Cases – Presented by Delegates
Precision Medicine: What’s Coming Next
Michel Gilliet, MD, Switzerland
Closing Comments
All Chairs
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.
